I will use lentivirus soon to integrate an shRNA in my cells. Unfortunately, the shRNA vector does not carry a fluorescent protein. How can I determine the titration of my lentivirus?
Depends on how accurate you will want to titer the vector. Without having a fluorescent marker gene you will have to use a qPCR based approach to get vector genome / ml titer. If you have LV with a GFP marker you can determine transducing units/ml and also run on qPCR along with your shRNA vector to estimate transducing units on your cell of interest. If you do this make sure that both vectors are pseudotyped with the same envelope
As an alternative can use p24 ELISA to estimate vector particles.
Hi Virginie. You can use qPCR for LV titration. There are many protocols available. We routinely employ the one published by Scherr et al. (BioTechniques,2001, 31:520-526) to titer ours (total LV per ul). It was described that 1% of total LV are TUs, which is true in our hands. You can find this pub in the protocol section of our website (www.rodriguezlab.com). Good luck! Cheers.
This is all you need to know (http://www.ncbi.nlm.nih.gov/pubmed/19300443). There are plenty protocols for qPCR titre determination of lenti - however the majority of these fall far short of the mark (ie they measure genome copies in a tube of 'purified virus'). What they don't generally take into account is the inefficiency of the packaging process (especially in the case of gene-modified lenti vectors (as opposed to wild type HIV)). This isn't restricted to lenti and applies to most (if not all) viral vectors used in gene therapeutic approaches. I'd strongly recommend the protocol in the attached paper (see 19.A) which requires the viral genome to be efficiently packaged, a virion produced, and that virion to infect a target cell (which is what you ultimiately want) and then assesses viral copy number per cell. It's the next best thing to flow cytometric analysis of cells infected with fluorescent protein expressing lenti's.
An alternative method to those described above is to determine your viral titer by infecting a target cell line, for example HEK 293 cells, followed by antibiotic selection. An advantage of this method of titration is that you will obtain the titer of intact infectious particles, whereas determination of viral genes by qPCR may overestimate your titer, particularly in case of low quality viral preparations. To be able to perform such experiments your lentiviral vector has to harbor an antibiotic resistance gene. Pseudotyping with VSV-G during viral packaging ensures that you will be able to infect a large panel of cells due to its broad cell tropism.
Here is a paper giving the pros and cons of each method. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1534021/
You could try using the p24 assay if you are looking for the titer prior to transducing, particularly if you have a specific MOI that you would like to use. It's quick and easy to do as it is an ELISA assay. I've used this routinely to titer my virus. Here is a link for the one that I use. For this kit, I make a 1 x10-6 dilution (in water) of concentrated virus (following 18 hour centrifugation) prior to adding the lysis buffer.
Let me know if you need any help with the protocol using this method.
Alternatively, If you want to check the level of transduction within your target cells, you can perform qPCR. http://www.clontech.com/US/Products/Viral_Transduction/Lentiviral_Transduction_Tools/Lentivirus_Titration/qRT-PCR
Determining the concentration of lentiviral particles is crucial for quantifying the amount of virus to be used in experiments. There are several methods to measure lentiviral titers, each with its own advantages and limitations:
P24 Antigen ELISA: This method quantifies the p24 protein, a viral capsid protein, present in the lentivirus preparation. The concentration of p24 correlates with the number of viral particles. This assay is relatively quick and provides a measure of the physical number of viral particles present.
Reverse Transcriptase Activity Assay: This assay measures the activity of the reverse transcriptase enzyme present in the lentivirus preparation. While this method gives an indication of the number of functional viral particles, it does not directly measure the infectivity of the virus.
Functional Titering (Transduction Units/mL):Infectious Unit Assay (IU/mL): This method involves transducing target cells with serial dilutions of the lentivirus and then measuring the expression of a reporter gene (like GFP) or a selectable marker (like puromycin resistance). The titer is calculated based on the percentage of transduced (infected) cells at each dilution. This method directly measures the number of infectious units per mL but can be labor-intensive and time-consuming. qPCR or RT-qPCR Based Assays: These assays measure the integration or the presence of viral RNA in transduced cells, providing a measure of infectious units. They are sensitive and specific but require standard curves for accurate quantification.
End-Point Dilution Assay (TCID50): This method involves infecting cells with serial dilutions of the virus and determining the dilution at which 50% of the wells/cultures show evidence of infection (cytopathic effect or reporter gene expression). This assay provides a measure of the number of infectious units but is more labor-intensive than direct measures like ELISA.
Each method has its own advantages and is suitable for different purposes. For instance, p24 ELISA and reverse transcriptase assays are quick and suitable for estimating the overall viral particle concentration, while functional titering methods like the infectious unit assay or qPCR-based assays provide a more accurate measure of the number of infectious particles, which is crucial for experiments where precise dosing is needed. The choice of method often depends on the resources available, the level of accuracy required, and the specific application of the lentivirus.
l With this protocol list, we might find more ways to solve this problem.